KYORIN Pharma, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 30%, Oct-Dec Ordinary Profit Decreases by 55%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Wed Feb 5, 2025 3:30 pm JST Earnings

4569 KYORIN Pharmaceutical Co.,Ltd. 【J-GAAP】

Earnings Report

KYORIN Pharmaceutical Co.,Ltd. <4569> [TSE Prime] announced its financial results after the market closed on February 5th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) dropped 30.4% from the same period last year to 3.75 billion yen. The progress rate toward the full-year plan of 6.9 billion yen was 54.4%, also falling below the five-year average of 76.0%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to surge 2.6 times that of the same period last year, reaching 3.14 billion yen.

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit significantly dropped to 1.7 billion yen, a 55.3% decrease compared to the same period last year. The operating profit margin sharply declined from 10.7% in the same period last year to 4.6%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2022	80,707	4,702	5,336	4,377	76.4	91.6	Feb 6, 2023	J-GAAP
Apr - Dec, 2023	87,267	4,803	5,391	4,149	72.3	81.7	Feb 6, 2024	J-GAAP
Apr - Dec, 2024	89,286	3,115	3,753	2,439	42.5	54.4	Feb 5, 2025	J-GAAP
YoY	+2.3%	-35.1%	-30.4%	-41.2%	-41.3%

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	64,595	4,678	5,024	3,432	59.8	32	May 10, 2024	J-GAAP
Oct - Mar, 2024 Guidance	68,261	4,951	4,850	3,745	65.2	32	Nov 7, 2024	J-GAAP
YoY	+5.7%	+5.8%	-3.5%	+9.1%	+9.0%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	113,270	5,123	5,827	4,723	82.4	52	May 11, 2023	J-GAAP
Mar, 2024	119,532	6,013	6,602	5,322	92.7	52	May 10, 2024	J-GAAP
Mar, 2025 Guidance	123,400	6,500	6,900	5,000	87.0	52	May 10, 2024	J-GAAP
YoY	+3.2%	+8.1%	+4.5%	-6.1%	-6.2%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	32,330	3,468	3,813	2,259	39.4	10.7	Feb 6, 2024	J-GAAP
Jan - Mar, 2024	32,265	1,210	1,211	1,173	20.4	3.8	May 10, 2024	J-GAAP
Apr - Jun, 2024	28,419	1,150	1,417	885	15.4	4.0	Jul 31, 2024	J-GAAP
Jul - Sep, 2024	26,720	399	633	370	6.4	1.5	Nov 7, 2024	J-GAAP
Oct - Dec, 2024	34,147	1,566	1,703	1,184	20.6	4.6	Feb 5, 2025	J-GAAP
YoY	+5.6%	-54.8%	-55.3%	-47.6%	-47.7%